Antony Mattessich Net Worth & Insider Trades

Antony Mattessich - President & CEO, Ocular Therapeutix, Inc

As of June 10, 2019

What is Antony Mattessich's Net Worth?

The current estimated net worth of Ocular Therapeutix, Inc's President & CEO, Antony Mattessich, is estimated to be about $3.7M . Antony Mattessich owns about 97,900 units of Ocular Therapeutix, Inc common stock. In the last 2 years at Ocular Therapeutix, Inc, Antony Mattessich has sold an estimated value of $0 worth.

What is Antony Mattessich's Past Insider Trading?

Antony Mattessich's largest purchase order was 20,000 units , worth over $119K on August 21, 2018. In total, Antony Mattessich has made about 4 transactions over 2 years of their time at Ocular Therapeutix, Inc. Antony Mattessich usually trades in August, with the busiest year in 2018. The most recent transaction was a purchase order of 40,000 units , worth over $112.4K on June 10, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Antony Mattessich's Salary in 2020?

As President & CEO of Ocular Therapeutix, Inc, Antony Mattessich has a total base salary of $600,000 . Antony Mattessich received compensation valued at about $2,163,150 in 2020 after becoming President & CEO.

What is Antony Mattessich's' Mailing Address?

  • Mailing address is C/o Ocular Therapeutix, Inc. 34 Crosby Dr., Suite 105 Bedford MA 01730 MA

Ocular Therapeutix, Inc Executive Compensation

Name
Year
Salary
Total
Antony Mattessich 2020 $600,000 $2,163,150
Antony Mattessich 2019 $581,796 $2,126,146
Michael Goldstein, M.D. 2020 $440,000 $1,336,250
Michael Goldstein, M.D. 2019 $423,906 $1,007,731
Philip C. Strassburger, Esq. 2020 $125,592 $2,413,764
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1393434/000155837021005257/tmb-20210618xdef14a.htm

What are Ocular Therapeutix, Inc's Past Insider Trades?

Ocular Therapeutix, Inc's most recent insider trade came on May 16, 2022 by Jeffrey S Heier who bought 15,000 units worth $45.75K . In the last 8 years, insiders at Ocular Therapeutix, Inc have sold an estimated value of $72.54M and bought an estimated value of $26.53M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Amarpreet Sawhney, Chairman the Board,  Charles M Warden, Director,  and Richard L. Lindstrom, M.D., Director .

OCULAR THERAPEUTIX, INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1